XNCR
Xencor, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +20.0% ·
share flow +0.9% ·
net new positions +16.7%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 28.43K | $398,504 | n/a | n/a |
| Q2 2026 | 80 | +2 | 51.89M | $834.92M | +6 | −4 |
| Q1 2026 | 81 | -4 | 48.47M | $584.53M | +2 | −7 |
| Q4 2025 | 85 | +1 | 50.89M | $779.05M | +3 | −1 |
| Q3 2025 | 16 | 0 | 41.61M | $488.08M | +1 | −2 |
| Q2 2025 | 14 | -1 | 41.55M | $326.56M | n/a | −1 |
| Q1 2025 | 12 | +2 | 20.83M | $221.62M | +3 | −1 |
| Q4 2024 | 10 | -2 | 20.65M | $474.47M | +1 | −3 |
| Q3 2024 | 11 | -2 | 20.50M | $412.29M | n/a | −2 |
| Q2 2024 | 13 | n/a | 17.96M | $339.91M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 9.76M | +8.6% | $103.86M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.93M | -2.6% | $41.82M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 3 | State Street Global Advisors ✦ (passive) | 3.68M | +15.1% | $39.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.67M | +2.4% | $17.82M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Point72 Asset Management ✦ | 1.02M | -53.0% | $10.89M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 305.13K | +2.7% | $3.25M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 152.40K | New | $1.62M | 0.0% | New | 1 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 108.87K | -26.4% | $1.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Millennium Management ✦ | 59.38K | New | $631,835 | 0.0% | New | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 58.48K | -51.1% | $622,270 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 41.13K | New | $437,592 | 0.0% | New | 1 | SEC ↗ ×4 |
| 12 | Wellington Management ✦ | 29.78K | +8.3% | $316,816 | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $1.62M | 0.0% |
| Millennium Management | $631,835 | 0.0% |
| AQR Capital Management | $437,592 | 0.0% |
Exited
| Baillie Gifford | $480,236 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 202 holders, 84.29M shares, $988.19M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.